The University of Hong Kong: Carcinoma trials
The registry lists 17 Carcinoma studies with The University of Hong Kong as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 9No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Immunotherapy and Radioembolisation for Metastatic Hepatocellular CarcinomaRecruitingNCT05809869Phase 2
- SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular CarcinomaStatus unknownNCT04913480Phase 2
- Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma PatientsStatus unknownNCT04601961Not applicable
- Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine LearningStatus unknownNCT04543266
- Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT04447612Phase 2
- Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPCCompletedNCT04396886Phase 2
- SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant WaitlistStatus unknownNCT03950102Not applicable
- Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal CarcinomaStatus unknownNCT03830996
- SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCCCompletedNCT03578874Phase 2
- Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous ChemotherapyWithdrawnNCT03390738Phase 2
- A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After RadiotherapyCompletedNCT03379610
- Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT02716766Phase 2
- Post-radiation Hypothyroidism After IMRT for Nasopharyngeal CarcinomaCompletedNCT02689609
- Serial Plasma EBV DNA for Nasopharyngeal CarcinomaStatus unknownNCT02476669
- Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal CarcinomatosisCompletedNCT02024841Phase 1
- Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular CarcinomaStatus unknownNCT00752063Phase 2
- Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCCCompletedNCT00234182Phase 1/2